Open AccessInfectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease–can we decrease the risk? Two case reports and review of literature
Author(s) -
Aleksandra Gładyś,
Sylwia Kozak,
Kamil Wdowiak,
Mateusz Winder,
Jerzy Chudek
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i3.748
Subject(s) - medicine , lymphoproliferative disease , lymphoproliferative disorders , transplantation , disease , infectious disease (medical specialty) , intensive care medicine , lymphoma
Post-transplant lymphoproliferative disease (PTLD) is a heterogeneous group of diseases that develop after solid organ and hematopoietic stem cells transplantation related to intensive immunosuppression regimen, T-cell depletion and Epstein-Barr virus infection. Despite the improvement in the management of PTLD, the prognosis remains poor. Here we report the management of two transplanted patients with PTLD and infections during immunochemotherapy (ICTH).